Clin2
NCT06511947Worth exploringRecruiting

Study of an inhaled drug in healthy volunteers

Healthy Volunteers

This trial tests how a new inhaled drug (GH001) moves through the body of healthy volunteers. It uses a special device to deliver the drug and checks how much gets into your blood.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
52 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • You are generally healthy and have no major medical conditions.
  • You have a BMI between 18.5 and 35.
  • Your mental health is good, as judged by the study doctor.
  • Your lung function is normal (tested by a breathing test).
  • You are not allergic to the study drug or related medicines (like melatonin or triptans).
  • You have not taken an experimental drug or vaccine in the last 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06532942Recruiting· Phase 1
Safety study of an inhaled drug in healthy adults

This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.

San Antonio, Texas
NCT06995326Not yet recruiting· Phase 1
Study of an experimental drug SGB-3383 in healthy volunteers

This trial tests an investigational drug in healthy people to see how safe it is and how the body processes it. It may help researchers decide if the drug should be studied further for a specific condition.

NCT07789899Recruiting· Phase 1
Safety study of a new investigational drug in healthy volunteers

This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.

Cambridge
NCT06166056Recruiting· Phase 1/Phase 2
Testing an inhaled medicine for bronchiectasis safety

This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.

Cambridge
NCT07540494Not yet recruiting· Phase 1
Safety and how the body processes GH001 inhalation in healthy people

This early-stage study tests a new inhaled medication called GH001 in healthy volunteers to understand how it's absorbed into the body and check for side effects. Researchers want to make sure it's safe before testing it in people with medical conditions.

Miami, Florida
NCT07510958Not yet recruiting· Phase 1
Testing an Inhaled Drug for Safety in Healthy Adults

This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.